Sign in
LOBEF Stock Price, Chart, Stats & News
Lobe Sciences Ltd.
Save
Lobe Sciences Ltd. (LOBEF) does not currently pay a dividend.
16.99M
Market cap
–
Current P/E
–
Forward P/E
LOBEF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Lobe Sciences Ltd. is a life sciences company focused on researching and advancing psychedelic-based medicines. Their primary therapeutic development involves psilocybin-derived treatments combined with N-acetylcysteine, specifically for addressing mild traumatic brain injuries (mTBI) and post-traumatic stress disorder (PTSD). Additionally, they engineer specialized devices aimed at enhancing the efficiency of drug administration.
Similar securities
Based on sector and market capitalization
Report issue